October 14, 2013
CASE CCC IN THE NEWS
BioMotiv Forms Second Spinoff Company with N.Y. Medical School
Cancer Patients, Survivors Turn Treatment Masks into Works of Art; Exhibit Runs Through Oct. 19
Trusting the Doctor
Non-specific and Specific RNA Binding Proteins Found to be Fundamentally Similar
Government shutdown, in its ninth day, continues to affect medical, scientific communities
Jackson Lab Article Highlighted as Top Science in Mammary Cell News
An article by Dr. Mark Jackson, "Tumor Microenvironmental Signaling Elicits Epithelial-Mesenchymal Plasticity through Cooperation with Transforming Genetic Events", was highlighted as the week's top science in the October 10 edition of Mammary Cell News.
MARK YOUR CALENDARS
New Treatment Paradigms for Melanoma: A Case-based Discussion
Registration is open for New Treatment Paradigms for Melanoma: A Case-based Discussion, presented by the Case Comprehensive Cancer Center on Friday, October 18 at the Holiday Inn-Cleveland South. This conference is intended to provide melanoma caregivers a case-driven overview of current melanoma treatment paradigms. Case CCC faculty will discuss multidisciplinary approaches to the management of early and late stage melanoma.
The conference will cover the integration of new diagnostic and treatment technologies in care of the melanoma patient. In addition, the role of new targeted and immune therapies in the melanoma treatment as well as management of associated novel toxicities will be reviewed. A case-based discussion format will provide the opportunity audience interaction with the course faculty. CME credit is available.
Graft-versus-Host Disease (GvHD) National Symposium
Registration today the Graft-versus-Host Disease (GvHD) National Symposium, Friday, November 1 at the Embassy Suites Cleveland. This conference is intended to raise awareness about the signs and symptoms of GvHD, review cutting edge approaches to prevention and treatment, and highlight and promote research to further our understanding of its cause. The symposium will have two tracks: a scientifically rigorous one for physicians and practitioners, and a survivor track that will focus on challenges faced by BMT recipients and their families. CME credit is available.
Regulatory Affairs 101: Navigating the FDA Process
The CWRU SOM is hosting a workshop, Regulatory Affairs 101: Navigating the FDA Process, on Tuesday, November 12 from 1-5 pm in the Wolstein Research Building Auditorium. This workshop is designed to provide investigators with awareness of regulatory requirements and acceptable standards for the conduct of clinical trials and the protection of human subjects. The desired outcome from this workshop is that researchers be able to understand the function of the FDA and Investigator responsibilities for those holding Investigational New Drug (IND) applications or Investigational Device Exemptions (IDE) or those investigators conducting research under and IND or IDE. CME/CREC credits are available. Pre-registration is required.
American Association for Cancer Research
The American Association for Cancer Research (AACR) is accepting applications for the following funding opportunities:
Limited Submission Reminder: NIH Director's Early Independence Awards
The NIH Director's Early Independence Awards provide an opportunity for exceptional junior scientists, who have already established a record of innovation and research productivity, to have an accelerated entry into an independent research career. It is also an opportunity for research intensive institutions to invigorate their research departments by recruiting outstanding, early career scientists. Exceptional graduate students or clinicians nearing the completion of their PhD (or equivalent) or for clinicians (MD or equivalent) the end of their medical residency may contact appropriate Institutional scientific leaders to seek an appointment as an independent research scientist. Each institution may nominate TWO candidates.
DOD Breast Cancer Research Program Postdoctoral Fellowship Award
Applications to the Fiscal Year 2013 Breast Cancer Research Program (BCRP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program, by the U.S. Army Medical Research Acquisitions Activity. The Postdoctoral Fellowship Award supports exceptionally talented recent doctoral or medical graduates in pursuit of innovative, high-impact breast cancer research during their postdoctoral training and allows them to obtain the necessary experience for an independent career at the forefront of breast cancer research. Those individuals should be exceptionally talented scientists who have demonstrated that they are the “best and brightest” of their peers. Applicants for this award must exhibit a strong desire to pursue a career in breast cancer research.
2014 CTSC Annual Pilot Grant Funding
The Clinical and Translational Science Collaborative (CTSC) of CWRU and the Case Coulter Translational Research Partnership (CCTRP) is accepting letters of intent for the 2014 CTSC Annual Pilot Grant Funding. The grant will support innovative translational research projects focused upon the invention, preclinical development and/or first in man studies of novel therapeutic agents, biomedical devices and diagnostics designed to address unmet clinical needs. The CTSC and CCTRP will provide seed money to faculty in multidisciplinary programs for Pilot Projects that will lead to efficient use of resources and support of inter-institutional, Clinical and Translational research in the City of Cleveland. Investigators in the basic science and clinical departments at CWRU, Cleveland Clinic, MetroHealth Medical Center, UHCMC and Louis Stokes Cleveland VA Medical Center are eligible. The PI is required to be a faculty member from one of the five CTSC partner institutions and eligible to be a PI for an NIH grant.
AACI Translational Cancer Research Fellowship
Association of American Cancer Institutes (AACI) is accepting applications for Translational Cancer Research Fellowships. The intent of the fellowship is to provide additional support to individuals who are engaged in any area of clinical and/or translational cancer research in order to further the development of their careers and enhance their future success in an academic discipline.
Applicants must be committed to advancing patient-oriented research. The successful applicant must:
Deadline: February 3, 2014
Pathology Pathology Research Seminar Series
Physiology and Biophysics Seminar
Skeletal Research Center
Radiation Oncology Grand Rounds
Immunology Seminar Series
Department of Medicine Grand Rounds
Hematology and Oncology Research Conference
Cancer Trainee Seminar
Immunology Journal Club
Prostate Cancer Working Group Seminar Series and Journal Club
Frontiers in Chemistry
Hematology/Oncology Fellows Conference/Curriculum Series canceled
Cancer Center Seminar Series canceled
New Treatment Paradigms for Melanoma: A Case-based Discussion
Taussig Cancer Institute Grand Rounds
Cellular and Molecular Medicine Seminar Series
BME Spotlight Seminar
University Hospitals Case Medical Center Candidate Seminar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
National GvHD Health Symposium
ADDITIONAL UPCOMING SEMINARS & EVENTS
15th Annual ASTRO Review 2013
13th Annual Multidisciplinary Genitourinary Oncology Course
PREVIOUSLY ANNOUNCED OPPORTUNITIES
Limited Submission: NSF Major Research Instrumentation Program
Stand Up To Cancer (SU2C)-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Translational Research Grant
NIH BULLETIN – Notices and Funding Opportunities
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to email@example.com.